Application no. and date | 12744254.9 (espacenet) (Federated) (European Patent Register), 20120210 | Patent/reg. no. and date | DK/EP 2673237, 20181107 | Publication date | 20131218 | Priority no. and date | US 201161441893 P, 20110211 | EP pub. no. and date |
EP 2673237 20131218 | Effective date | | Applicant/owner | ZS Pharma, Inc, 508 Wrangler Dr., Suite 100
Coppell, TX 75019-7609, US | Applicant ref. no. | D. Young & Co. LLP P103177EPCFC | Inventor | KEYSER, Donald, Jeffrey, 1216 Wyndham Hill Lane
Southlake, Texas 76092, US, GUILLEM, Alvaro, F., 727 Lathrop Street
Lantana, Texas 76226, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 33/00 (2006.01) , A61K 33/24 (2006.01) , A61K 45/06 (2006.01) , A61K 9/14 (2006.01) , B01J 19/00 (2006.01) , B01J 19/18 (2006.01) , B01J 39/02 (2006.01) , B01J 39/14 (2006.01) , C01B 33/20 (2006.01) , C01B 39/02 (2006.01) , C01B 39/46 (2006.01) , C07F 7/02 (2006.01) | Title | ANVENDELSE AF ET ZIRCONIUMSILICAT TIL BEHANDLING AF HYPERKALIÆMI | Int. application no. | US2012024727 | Int. publication no. | WO2012109590 | Related patent (certificate) | CA 2019 00014 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|